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Accelerated aneurysmal dilation associated with
apoptosis and inflammation in a newly developed
calcium phosphate rodent abdominal aortic
aneurysm model
Dai Yamanouchi, MD, PhD, Stephanie Morgan, BS, Colin Stair, BS, Stephen Seedial, BS,
Justin Lengfeld, BS, K. Craig Kent, MD, and Bo Liu, PhD, Madison, Wisc
Objective: The calcium chloride (CaCl2) model is a widely accepted rodent model for abdominal aortic aneurysms (AAAs).
Calcium deposition, mainly consisting of calcium phosphate (CaPO4) crystals, has been reported to exist in human and
experimental aneurysms. CaPO4 crystals have been used for in vitro DNA transfection by mixing CaCl2 and phosphate-
buffered saline (PBS). Here, we describe accelerated aneurysm formation resulting from a modification of the CaCl2 model.
Methods: A modified CaCl2 model, the CaPO4 model, was created by applying PBS onto the mouse infrarenal aorta after
CaCl2 treatment. Morphologic, histologic, and immunohistochemical analyses were performed on arteries treated with
the CaPO4 model and the conventional CaCl2 model as the control. In vitro methods were performed using a mixture of
CaCl2 and PBS to create CaPO4 crystals. CaPO4- induced apoptosis of primary cultured mouse vascular smooth muscle
cells (VSMCs) was measured by DNA fragmentation enzyme-linked immunosorbent assay.
Results: The CaPO4 model produces AAA, defined as an increase of >50% in the diameter of the aorta, faster than in the
CaCl2 model. The CaPO4 model showed significantly larger aneurysmal dilation at 7, 28, and 42 days, as reflected by a
maximum diameter (measured in mm) fold-change of 1.69  0.07, 1.99  0.14, and 2.13  0.09 vs 1.22  0.04, 1.48
 0.07, and 1.68 0.06 in a CaCl2 model, respectively (n 6; P< .05). A semiquantitative grading analysis of elastin fiber
integrity at 7 days revealed a significant increase in elastin degradation in the CaPO4 model compared with the CaCl2 model
(2.70.2 vs 1.50.2; n6;P< .05). A significantly higher level of apoptosis occurred in theCaPO4model (apoptosis index
at 1, 2, and 3 days postsurgery: 0.26 0.14, 0.37 0.14, and 0.33 0.08 vs 0.012 0.10, 0.15 0.02, and 0.12 0.05
in the conventional CaCl2 model; n  3; P < .05). An enhancement of macrophage infiltration and calcification was also
observed at 3 and 7 days in the CaPO4 model. CaPO4 induced approximately 3.7 times more apoptosis in VSMCs than a
mixture of CaCl2 (n  4; P < .0001) in vitro.
Conclusions: The CaPO4 model accelerates aneurysm formation with the enhancement of apoptosis, macrophage
infiltration, and calcium deposition. This modified model, with its rapid and robust dilation, can be used as a new model
for AAAs. (J Vasc Surg 2012;56:455-61.)
Clinical Relevance: Animal models of abdominal aortic aneurysms (AAAs) have been used in a range of experiments to
explore various aspects of pathogenesis and potential methods of treatment. The conventional calcium chloride (CaCl2)
model has been widely accepted as an experimental animal model with many pathologic similarities with human AAAs.
This conventional model typically shows aneurysmal dilation at 4 to 6 weeks after injury. We have created a mouse
experimental AAAmodel with rapid and robust aneurysmal dilation through the modification of the conventional CaCl2










0Abdominal aortic aneurysm (AAA) is a common vascu-
lar disease associated with high mortality. Aneurysm results
from the culmination of a series of events that lead to
disruption of structural integrity and segmental weakening
of the abdominal aortic wall. AAA is the 10th leading cause
of death in men aged 55 years and causes as many as
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d0,000 deaths each year in the United States.1 The preva-
ence of AAAs increases continuously in men aged 55
ears and reaches an estimated peak of10% in those aged
0 to 85 years.2
Several animal models have been created to aid investi-
ation of pathophysiologic events underlying human
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ical manipulation, or both.3 Genetic manipulations are
often associated with defects in extracellular matrix matu-
ration, disruption of lipid homeostasis, or alteration of
angiotensin enzymes.4-7 The chemically induced aneurysm
approaches include the intraluminal infusion of elastase and
the periaortic application of calcium chloride (CaCl2). A
third chemical approach combines chemical and genetic
approaches, using a systemic infusion of angiotensin II to
mice genetically altered to compromise lipid homeostasis
such as mice deficient in apolipoprotein E or low-density
lipoprotein receptor.8-11
Aneurysmal changes in the carotid artery of hyperlipid-
emic rabbits resulting from periaortic application of CaCl2
was first described by Gertz et al.12 This method was later
applied in the abdominal aortas of hyperlipidemic rabbits in
combination with thioglycollate, as reported by Freestone
et al13 and subsequently adapted to mice.10,14 By applying
CaCl2-soaked gauze to the infrarenal aorta for 15 to 20
minutes, one can typically generate aneurysmal dilation in
the treated aortic segment within 4 to 6 weeks.14,15 This
model does not require the use of genetically modified
mice. Similar to the elastase-induced mouse aneurysm,
CaCl2-induced aneurysmal dilation is accompanied by the
depletion of medial layer smooth muscle cells (SMCs), as
well as elastin degradation, infiltration of lymphocytes
and macrophages, elevation of proinflammatory cyto-
kines, and the increased activation of matrix metallopro-
teinases.10,14,15
The mechanism by which the adventitial application of
CaCl2 causes these molecular and cellular changes in the
aortic wall is not entirely clear. Previous findings have
identified calcium ion binding sites on both collagen and
elastin, suggesting that CaCl2 application may facilitate the
degradation of these major arterial structural compo-
nents.16 Our group has identified significant calcification
also occurring in CaCl2-treated arteries, mainly in the me-
dial layer. We hypothesized that this calcificationmight also
contribute to aneurysm formation and explored the forma-
tion of these calcification deposits. Calcium phosphate
(CaPO4) crystals have been identified as the major compo-
nent of calcification found in atherosclerosis17-19 and have
been suggested to have significant proinflammatory effects,
induce apoptosis in various cell types, and stimulate pro-
duction of proinflammatory cytokines from monocytes,
macrophages, and SMCs.20,21
In the current study, we tested whether CaPO4 is a
more potent stimulus than CaCl2 in stimulation of apopto-
sis and induction of inflammatory cytokines. Based on the
CaPO4-based cell transfection method, we adapted a
method of CaPO4 generation in vivo through a sequential
application of CaCl2 and phosphate-buffered saline
(PBS).22-24 Compared with the application of CaCl2 alone,
the sequential application of CaCl2 and PBS produces a
more severe, rapid dilation of the aneurysmal artery associ-
ated with significantly enhanced smooth muscle apoptosis
and inflammatory responses. Although future studies are
necessary to determine how this new method, termed the CaPO4 model, may cause arterial injury, its rapid induction
f aneurysmal dilation is advantageous and could be used as
n additional rodent model in studies of AAA.
ETHODS
All animal procedures in this study were conducted in
ccordance with experimental protocols that were ap-
roved by the Institutional Animal Care and Use Commit-
ee at the University of Wisconsin, Madison (Protocol
02284).
General materials. Dulbecco’s modified Eagle’s me-
ium (DMEM) and cell culture reagents were from Gibco
RL Life Technologies, Grand Island, NY. Chemicals, if
ot specified, were purchased from Sigma Chemical Co (St.
ouis, Mo).
Mouse models of AAAs. Male 12-week-old C57BL/6
ice were purchased from Jackson Laboratory (Bar Harbor,
e). All mice had free access to a normal diet and water.
he CaPO4-induced AAA model was created through a
ethod closely resembling the CaCl2-induced model as
escribed by Gertz et al.12 Under general anesthesia, the
nfrarenal region of the abdominal aorta was isolated
hrough amidline incision. A small piece of gauze soaked in
.5mol/LCaCl2 was applied perivascularly for 10minutes.
his gauze was replaced with another piece of PBS-soaked
auze for 5 minutes. The CaCl2-induced aneurysm was
reated through a similar manner but with one 15-minute
reatment of gauze soaked with 0.5 mol/L CaCl2. Control
ice received one treatment of 0.5 mol/L sodium chloride
NaCl)-soaked gauze for 15 minutes.
Histologic analyses suggest that vascular injury appears
o be more severe at the anterior surface where arterial
issue comes in contact with gauzes. The maximum exter-
al diameter of the infrarenal aorta was measured using a
igital caliper (VWR Scientific, Radnor, Pa) before treat-
ent and at the time of tissue harvest.
At selected intervals, mice were euthanized and tissues
ere perfusion-fixed with a mixture of 4% paraformalde-
yde in PBS at physiologic perfusion pressure. Harvested
issue was further fixed in 4% paraformaldehyde and imbed-
ed in optimal cutting temperature compound (Sakura
issue Tek, Alphen aan den Rijn, The Netherlands). All
ections were cut 6-m thick using a Leica CM3050S
ryostat.
Histology and immunohistochemistry. Samples
ere stained with van Gieson using the Chromaview Van
ieson kit (Richard-Allan Scientific, Kalamazoo, Mich)
ccording to the provided protocol. Elastin integrity was
uantified using a grading system as described by Kita-
onto et al25: no elastin degradation or mild elastin deg-
adation, 1; moderate, 2; moderate to severe, 3; and severe
lastin degradation, 4. Each section was numbered and
hotographed at original magnification 10 or 20,
aintaining their respective numbers. Then, an objective
articipant used the scale to grade the photographs and
ecorded the grade with the section number.
Calcification was detected using Alizarin Red (Ricca
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Volume 56, Number 2 Yamanouchi et al 457content was calculated using ImageJ Software (National
Institutes of Health, Bethesda, Md). Total area of calcified
media (stained red) was calculated and divided by total
medial area of the artery to yield the reported ratio(s).
For additional immunohistochemistry, arterial sections
were permeabilized with 0.1% TritonX for 10 minutes at
room temperature. Nonspecific sites were blocked using 5%
bovine serum albumin and 3% normal donkey serum in
Tris-buffered saline and Tween 20 for 1 hour at room
temperature. Primary antibodies to CD3, monocyte che-
moattractant protein-1 (MCP-1), and Mac3 were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, Calif),
anti-monocyte/macrophage-specific antibody (MOMA2)
was purchased from Abcam (Cambridge, Mass), cleaved
caspase 3 was purchased from Cell Signaling Technology
(Boston, Mass), and smooth muscle- actin (SMA) was
purchased from Sigma-Aldrich (St. Louis, Mo).
Primary antibodies were diluted in previously described
blocking solution and incubated overnight at 4°C. Apopto-
sis was identified through terminal deoxynucleotide
transferase-mediated deoxy uridine triphosphate nick-end
labeling (TUNEL) in an In Situ Cell Death Detection Kit
(Roche, Indianapolis, Ind) according to kit directions.
Fluorescent stains were completed using secondary anti-
bodies purchased from Invitrogen Molecular Probes
(Carlsbad, Calif), and 4=,6-diamidino-2-phenylindole
(DAPI; Invitrogen) was used to detect nuclei. Staining was
visualized with a Nikon Eclipse E600 upright microscope,
and digital images were acquired using a RetigaEXi CCD
digital camera. Quantification of stains was performed in a
manner to that previously described26 using ImageJ Soft-
ware. Data quantification was performed using at least
three sections per artery.
Cell culture. Primary mouse aortic SMCs from the
aorta of C57BL/6 mice were isolated by using a protocol
described by Clowes et al.27 Briefly, aortas were perfused
with PBS supplemented with 2% penicillin/streptavidin
antibiotics. The aorta was isolated from the aortic arch to
the iliac bifurcation and incubated 30 minutes in digestion
buffer at 37°C. Adventitia was pulled away from the medial
layer, and tissues were minced and further incubated for 4
hours at 37°C. Cells isolated from the medial layer of
individual mice were kept in separate dishes to allow a
biologic replicate from each animal. Tissue was spun to a
pellet by centrifugation and washed with 10% fetal bovine
serum (FBS) DMEM once, then suspended in a small
volume of 10% FBS DMEM and left undisturbed for 48
hours to allow cells to migrate from the tissue. All cell types
were maintained in DMEM supplemented with 10% fetal
calf serum, 100 U/mL penicillin, and 100 g/mL strep-
tomycin in a 5% CO2/water-saturated incubator at 37°C.
In vitro CaCl2 and CaPO4 treatments. The 10%
FBSDMEMwas replaced with 0.5% FBSDMEM24 hours
before all cell treatment. Cells designated for CaCl2 treat-
ment were washed with normal saline twice before being
treated with CaCl2 (final concentration 0.05 mol/L) di-
luted in normal saline. Treated cells were incubated at 37°C
for 15 minutes, the CaCl2 solution was removed, and cells Sere washed twice with 10% FBS DMEM and let rest 6
ours at 37°C. Cells designated for CaPO4 treatment were
ashed twice with 1 PBS before being treated with CaCl2
final concentration 0.05 mol/L) diluted in 1 PBS for 15
inutes. The remainder of the treatment method was the
ame as the CaCl2 group.
DNA fragmentation enzyme-linked immunosor-
ent assay. In vitro detection of apoptosis via fragmented
NA labeling was done using the Cell Death Detection
nzyme-linked immunosorbent kit (Roche) according to
he manufacturer’s protocol.
Flow cytometric analysis. Apoptotic populations in
reated cell groups were assessed by flow cytometry using a
E Annexin V Apoptosis Detection Kit (BD Pharmigen,
ig 1. Apoptosis induced by calcium phosphate (CaPO4) treat-
ent in vitro. Cultured mouse aortic smooth muscle cells (SMCs)
ere treated with calcium chloride (CaCl2) or CaPO4 as described
n the Methods section. A, In vitro apoptosis determined by DNA
ragmentation enzyme-linked immunosorbent assay. Fold-change
as determined with comparison to untreated cell group (control;
 4). *P  .0001. B, Representative results of flow cytometry
nalyses. Apoptotic and necrotic cells were identified by annexin V
nd 7-aminoactinomycin D (7AAD), respectively (n  4). The
rror bars show the standard error.
able. Analysis of cells after treatment with calcium
hloride (CaCl2) or calcium phosphate (CaPO4), shown




(Negative) (Annexin V) (7AAD) (Double)
aCl2 89.2  1.27 1.08  0.01 2.79  2.35 6.94  1.02
aPO4 22.0  7.92
a 68.8  7.6a 1.4  0.23 7.8  0.14
ADD, 7-aminoactinomycin D.
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Flow Cytometer equipped with a Cytek 633-nm laser
(Freemont, Calif) and analysis was performed using FlowJo
software (TreeStar Inc, Ashland, Ore).
Statistical analysis. Values are expressed as means 
standard error. Experiments were repeated at least three
times, unless stated otherwise. Differences between two
groups were analyzed by the Student t-test. One-way anal-
ysis of variance, followed by the Scheffe test, was used for
multiple comparisons. Values of P  .05 were considered
significant.
RESULTS
CaPO4 induces apoptosis in aortic SMCs. Primary
cultured mouse aortic SMCs were treated with CaCl2 or
CaPO4; control SMCs were similarly treated with normal
saline. At the end of treatment, cells were placed into
normal growth media for 6 hours before undergoing apo-
ptotic evaluation. Analyses of DNA fragmentation indi-
cated the presence of apoptotic cells in CaCl2- and CaPO4-
treated cells; however, CaPO4 induced approximately 3.7
times more apoptosis of SMCs than CaCl2 (P .0001; Fig
1, A). Detailed cell profiling by FACS analysis showed that
most of the dead cells in the CaCl2-treated group stained
positive for annexin V and 7-aminoactinomycin D, indicat-
ing secondary necrosis. However, most of the dead cells in
Fig 2. Mice were subjected to abdominal aortic aneurys
phosphate (CaPO4) and were euthanized at indicated ti
pictures of arterial dilation 7 days after surgery. B,Quant
after surgery (n  6). Fold-change calculated as maximu
stain shows elastin layer degradation in representative tr
Semiquantification of elastin degradation in arteries harv
error.the CaPO4-treated group stained positive only for annexin a, indicating apoptosis to dominate this treatment group
Fig 1, B; Table).
CaPO4 exacerbates aneurysm formation in mice.
o facilitate CaPO4 crystal formation in vivo, we sequen-
ially applied CaCl2 and PBS, or CaCl2 alone as a control, to
he adventitial surface of mouse abdominal aorta. Mice
ere euthanized at designated intervals after the injury, and
he maximum diameter of the aortas was measured. Aneu-
ysm development was assessed by determining the fold-
hange in diameter, calculated as the postsurgical measure-
ent divided by the diameter measured before injury. As
hown in Fig 2, the aortas treated by CaPO4 showed
ignificantly larger aneurysmal dilation at 7, 28, and 42
ays, as reflected by a maximum diameter fold-change of,
espectively, 1.69 0.07, 1.99 0.14, and 2.13 0.09 in
he CaPO4 model vs 1.22  0.04, 1.48  0.07, and 1.68
0.06 in the CaCl2model (n 6; P .05; Fig 2,A and B).
he van Gieson staining of the aortic wall at day 7 showed
ore fragmentation of the elastin layer in CaPO4-treated
ortas (Fig 2, C). A semiquantitative grading analysis of
lastin fiber integrity at 7 days revealed a significant increase
n elastin degradation in the CaPO4 model compared with
he CaCl2 model (Fig 2, D).
CaPO4 intensifies apoptosis in aneurysmal arteries.
ext, we compared the magnitude of apoptosis after aneu-
ysm induction with CaCl or CaPO by harvesting arteries
A) induction with calcium chloride (CaCl2) or calcium
s described in the Methods section. A, Representative
ion of arterial expansion measured 3, 7, 28, and 42 days
ameter/presurgery diameter. *P  .05. C, Van Gieson
arteries 7 days after surgery. Scale bar  100 m. D,
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Volume 56, Number 2 Yamanouchi et al 459was evaluated by TUNEL staining at each interval. CaPO4
injury induced significantly more apoptosis than CaCl2
injury at 2 and 3 days after injury (Fig 3, A and B, respec-
tively). Most of the apoptotic cells were noted in the media
and localized to cells that were positive for SMA (Supple-
mental Fig 1, online only).
CaPO4-induced aneurysm is associated with in-
flammation and medial calcification. A prevalent feature
of human and experimental aneurysms is significant inflam-
matory infiltrate. We have previously reported a relation-
ship between apoptosis of SMCs and the inflammatory
response(s) leading to the infiltration of macrophages and
other inflammatory cells to the aortic wall.28 At this notion,
CaPO4-treated arteries were stained for the presence of
macrophages, as identified by the marker CD68. CaPO4-
treated arteries harvested 3 days after injury showed signif-
icant macrophage infiltration (Fig 4, A). The graph in Fig
4, B shows macrophage infiltration as determined by
CD68-positive cells divided by total nuclei. Supplemental
Fig 2 (online only) depicts additional inflammatorymarkers
in day 3 CaPO4-treated arteries. Macrophage marker
Mac3, T-lymphocyte marker CD3, and the inflammatory
cytokine MCP-1 evidenced a significant inflammatory
response.
Using cleaved (activated) caspase 3 as a marker for
apoptosis, we evaluated the spatial relationship between
apoptosis and inflammation. Monocytes and macrophages,
Fig 3. Calcium phosphate (CaPO4)-induced aneurysm displays
apoptosis. Mice underwent abdominal aortic aneurysm induction
with calcium chloride (CaCl2) or CaPO4 and were euthanized at
indicated times as described in the Methods section. A, Represen-
tative images of immunohistochemistry for apoptosis, as measured
by terminal deoxynucleotide transferase-mediated deoxy uridine
triphosphate nick-end labeling (TUNEL; red), nuclei shown by
4=,6-diamidino-2-phenylindole (DAPI) stain (blue) in treated ar-
teries 3 days after injury. Scale bar 100 m. B, TUNEL index as
determined by TUNEL-positive cells/nuclei.Measurements taken
from CaCl2-treated (black bar) and CaPO4-treated (white bars)
arteries harvested 24, 48, or 72 hours after surgery (n  3). *P 
.05. The error bars show the standard error.marked byMOMA, localizedmostly in the adventitia (Sup- clemental Fig 3,A, online only). Using cleaved or activated
aspase 3 as a marker for apoptosis, we found that most of
he monocytes and macrophages at this interval were not
poptotic; however, they tended to concentrate in areas
roximal to apoptotic cells (Supplemental Fig 3, online
nly).
Significant calcification in CaPO4-treated arteries
as easily noted visually and tactilely at the time of artery
arvest. Cross-sections of the aortas receiving treatment
ith CaCl2 or CaPO4 injury were stained with Alizarin
ed according to manufacturer’s protocol. CaPO4 injury
aused pronounced medial calcification appearing 	48
ours after injury and maximizing at 	7 days (Fig 5, A
nd B).
ISCUSSION
Animal models of AAAs have been used in a range of
xperiments to explore various aspects of AAA pathogene-
is as well as potential methods of AAA treatment. Here, we
eport the creation of a mouse experimental AAA model
ith rapid and robust aneurysmal dilation through sequen-
ial adventitial application of CaCl2 and PBS. This modified
aCl2 model, or the CaPO4 model, displayed similar
athologic and histologic characteristics as the previously
escribed CaCl2 model but at a higher magnitude.
We postulate that adventitial insult in the form of
aCl2 application causes a series of tissue degenerative
vents, at least partly through formation of CaPO4 crystals.
upporting this argument is our finding that CaCl did not
ig 4. Inflammation accompanies calcium phosphate (CaPO4)-
nduced aneurysm. Mice underwent abdominal aortic aneurysm
nduction with calcium chloride (CaCl2) or CaPO4 and were
uthanized at indicated intervals as described in the Methods
ection. A, Representative images are shown of immunohisto-
hemistry for macrophage marker CD68 (green) in CaCl2-treated
nd CaPO4-treated aortas 3 days after injury. Nuclei stained with
=,6-diamidino-2-phenylindole (DAPI; blue). Scale bar  100
m. B, Macrophage infiltration as determined by CD68-positive
ells/nuclei in treated arteries 24, 48, and 72 hours after treatment
n  3). *P  .05. The error bars show the standard error.2
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August 2012460 Yamanouchi et alapplied to cultured mouse aortic SMCs. In contrast, cul-
tured mouse aortic SMCs responded to CaPO4 with mas-
sive apoptosis, findings consistent with reports from other
groups.20,21,29
Although the creation of an aneurysm phenotype with
CaCl2 or CaPO4 is artificial, atherosclerotic calcification has
been shown to consist mainly of CaPO4 crystals, which is
typically seen in the intimal and medial layer of the diseased
human aorta.18,19,30 We observed medial calcification in
the arterial segments that sustained the CaCl2 or CaPO4
insult. Although tactile and immunohistochemical meth-
ods show substantial calcification in these arteries, the
biologic mechanisms underlying this ectopic calcification
have yet to be identified. Thus, future studies may lend
insight to these processes through identification of
calcification-regulating genes such as osteopontin.
Interestingly, robust apoptosis and calcification was
observed in the medial layer of the aorta starting at	2 days
after surgery, at which time the elastin fibers appeared
grossly intact.
A potential causal relationship between apoptosis and
calcification has been conceptualized by Proudfoot et al,31
who propose a model in which SMC death may form
apoptotic bodies in the arterial wall, which in turn may
serve as a nucleus for vascular calcification.32 In our time
course studies, we noted the time line of apoptotic induc-
tion in the arterial wall, which began at 	24 hours, was
closely followed by the detection of calcium deposition at
	48 hours after injury. However, the link between SMC
apoptosis and medial calcification has yet to be directly
tested. Aortic calcification has been reported in human
AAAs,33 but the precise contribution calcification may
Fig 5. Calcium phosphate (CaPO4)-induced aneurysm
stained with Alizarin Red for calcium deposit detection.
control sections were harvested from animals treated wit
and at 7 days after CaPO4 treatment. Scale bar 200 m
sections harvested from arteries with the conventional
expressed as a ratio of the total calcified media divided by
bars show the standard error.make toward aneurysm progression is still controversial. rOne important limitation within this study lies in the
ormation of the CaPO4 crystals. Although mixing CaCl2
ith PBS generates these crystals, this method provides no
eans of controlling the formation of CaPO4 crystals or of
easuring the final concentration or composition of these
rystals, especially in vivo. In preliminary studies, we tested
he periaortic application of several forms of CaPO4, in-
luding hydroxyapatite, nanocrystal, and basic CaPO4.
owever, each of these forms of CaPO4 failed to induce
neurysm formation in vivo and produced little if any
poptosis in vitro. One possible explanation for this signif-
cant difference among the types of CaPO4 crystal is that
he size variation, particularly compared with the naturally
ormed crystals, may not be appropriate for the endocytosis
r autophagocytosis of these crystals to induce apopto-
is.34,35 To address a few questions surrounding the role of
hese CaPO4 crystals, methods of interfering with crystal
ormation or the chemical reaction(s), or both, that take
lace might provide mechanistic insights. Although the
cope of this study does not allow such an experiment,
uture work must explore these methods to fully under-
tand the role of CaPO4 crystals in this newly described
odel. Furthermore, a better understanding of the role of
alcification in aneurysms is necessary to fully understand
he potential effect of this study.
ONCLUSIONS
We have shown that the creation of a CaPO4 mouse
AA model through the modification of the conventional
aCl2 model significantly accelerates aneurysm formation.
aPO4 treatment also induced significant enhancement of
poptosis both in vitro and in vivo. Calcification and mac-
les contain medial calcification. A, Arterial sections were
ium appears red on a pink and yellow background. The
ne only. Sections were harvested at 48 hours, 72 hours,
l images.B,Quantification of calcium content in arterial
um chloride (CaCl2) or the CaPO4 model. Data are
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Volume 56, Number 2 Yamanouchi et al 461CaPO4 aneurysm, sharing spatial and temporal similarities
to the apoptosis within the medial layer. This model, with
its rapid and robust dilation, can be utilized as a new model
for mouse experimental AAAs.
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